Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
J Allergy Clin Immunol Pract
; 10(2): 558-565.e4, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34757063
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pharmaceutical Preparations
/
Eosinophilia
/
Drug Hypersensitivity Syndrome
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
J Allergy Clin Immunol Pract
Year:
2022
Document type:
Article
Affiliation country:
Japón
Country of publication:
Estados Unidos